DK135887A - Human-vaevstype-plasminogenaktivator-polypeptider og fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse - Google Patents

Human-vaevstype-plasminogenaktivator-polypeptider og fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse

Info

Publication number
DK135887A
DK135887A DK135887A DK135887A DK135887A DK 135887 A DK135887 A DK 135887A DK 135887 A DK135887 A DK 135887A DK 135887 A DK135887 A DK 135887A DK 135887 A DK135887 A DK 135887A
Authority
DK
Denmark
Prior art keywords
human tissue
procedures
type plasminogen
production
pharmaceutical preparations
Prior art date
Application number
DK135887A
Other languages
English (en)
Other versions
DK175490B1 (da
DK135887D0 (da
Inventor
Adair John Hotchkiss
John Vincent O'connor
Michael Walter Spellman
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK135887D0 publication Critical patent/DK135887D0/da
Publication of DK135887A publication Critical patent/DK135887A/da
Application granted granted Critical
Publication of DK175490B1 publication Critical patent/DK175490B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK198701358A 1986-03-18 1987-03-17 Human-vævstype-plasminogenaktivator-polypeptider og fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende disse DK175490B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84107586A 1986-03-18 1986-03-18
US84107586 1986-03-18
US2189387A 1987-03-04 1987-03-04
US2189387 1987-03-04

Publications (3)

Publication Number Publication Date
DK135887D0 DK135887D0 (da) 1987-03-17
DK135887A true DK135887A (da) 1987-09-19
DK175490B1 DK175490B1 (da) 2004-11-08

Family

ID=26695219

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198701358A DK175490B1 (da) 1986-03-18 1987-03-17 Human-vævstype-plasminogenaktivator-polypeptider og fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende disse

Country Status (19)

Country Link
EP (1) EP0238304B1 (da)
JP (1) JP2972812B2 (da)
AT (1) ATE139569T1 (da)
AU (1) AU602510B2 (da)
CA (1) CA1341597C (da)
DD (1) DD258999A5 (da)
DE (2) DE3751842T2 (da)
DK (1) DK175490B1 (da)
ES (1) ES2088860T3 (da)
FI (1) FI100802B (da)
FR (1) FR2597883B1 (da)
GB (1) GB2189249B (da)
GR (1) GR3020850T3 (da)
HU (1) HU202276B (da)
IE (1) IE81073B1 (da)
IL (1) IL81937A (da)
NO (1) NO172133C (da)
NZ (1) NZ219654A (da)
PT (1) PT84493B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0124613B1 (en) * 1982-10-29 1992-12-30 MITSUI TOATSU CHEMICALS, Inc. Novel plasminogen activator derived from human kidneys, process for its preparation, and thrombolytic drug containing the same
NZ213647A (en) * 1984-10-01 1989-05-29 Integrated Genetics Inc Recombinant human tissue plasminogen activator (tpa) modified in n-linked glycosylation pattern
US5108909A (en) * 1985-03-22 1992-04-28 Chiron Corporation Expression of TPA in mammalian cells
ATE74379T1 (de) * 1985-12-23 1992-04-15 Chiron Corp Peptidplasminogenaktivatoren.
EP0293394B2 (en) * 1986-01-31 2003-10-29 Genetics Institute, LLC Novel thrombolytic proteins
US4927630A (en) * 1986-02-26 1990-05-22 Monsanto Company Tissue plasminogen activator from normal human colon cells
US4851517A (en) * 1986-02-26 1989-07-25 Monsanto Company Tissue plasminogen activator oligosaccharide from normal human colon cells
JPH084501B2 (ja) * 1987-03-20 1996-01-24 エーザイ株式会社 糖鎖に関する変異ｔＰＡ
IE64782B1 (en) * 1987-06-04 1995-09-06 Eisai Co Ltd Mutant t-PA with kringle replacement
DK359888A (da) * 1987-07-01 1989-01-02 Beecham Group Plc Fibrinolytisk enzym
US5244676A (en) * 1987-10-09 1993-09-14 Monsanto Company Modified tissue plasminogen activator with modified glycosylation site
IL88247A0 (en) * 1987-11-06 1989-06-30 Genentech Inc Novel human tissue-type plasminogen activator variant
IL90146A (en) * 1988-05-20 1994-10-07 Genentech Inc Glycosylation derivatives of tissue plasminogen activator
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
US5346824A (en) * 1988-05-20 1994-09-13 Genentech, Inc. DNA encoding variants of tissue plasminogen activators and expression vectors and hosts thereof
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
DE3841296A1 (de) * 1988-12-08 1990-06-13 Bosch Gmbh Robert Antiblockierregelsystem
US5070021A (en) * 1989-01-10 1991-12-03 Monsanto Company Method of modifying oligosaccharide structure of tissue plasminogen activator
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
US5223408A (en) * 1991-07-11 1993-06-29 Genentech, Inc. Method for making variant secreted proteins with altered properties
DK0643772T3 (da) 1992-06-03 1998-02-02 Genentech Inc Glycosyleringsvarianter af vævsplasminogenaktivator med forbedrede terapeutiske egenskaber
US6706504B1 (en) 1996-11-12 2004-03-16 The Scripps Research Institute Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
JP4543131B2 (ja) 1999-04-26 2010-09-15 ジェネンテック， インコーポレイテッド 糖タンパク質のための細胞培養方法
US7084118B2 (en) 2002-02-22 2006-08-01 Genentech, Inc. Combination treatment with t-PA variant and low molecular weight heparin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR840004781A (ko) * 1982-05-05 1984-10-24 월터 에이치·드레거 인체의 조직 플라스미노겐 활성화제
WO1984001786A1 (en) * 1982-10-28 1984-05-10 Beecham Group Plc Enzyme derivatives and their use in the treatment of thrombosis
WO1984001960A1 (en) * 1982-11-11 1984-05-24 Beecham Group Plc Pharmaceutically active compounds
NZ213647A (en) * 1984-10-01 1989-05-29 Integrated Genetics Inc Recombinant human tissue plasminogen activator (tpa) modified in n-linked glycosylation pattern
JPS61247384A (ja) * 1984-10-18 1986-11-04 チモ−ジエネテイツクス　インコ−ポレ−テツド 酵母中でプラスミノ−ゲン活性化因子を発現する方法
DE3537176C2 (de) * 1984-10-18 1994-06-09 Zymogenetics Inc Gewebeplasminogenaktivator und Verfahren zu seiner Herstellung
HU206520B (en) * 1985-04-22 1992-11-30 Genentech Inc Process for producing new human tissue plasminogen activator /tpa/ mutants and pharmaceutical compositions containing them
JPH0811066B2 (ja) * 1985-09-30 1996-02-07 インテグレーテッド・ジエネティックス・インコーポレーテッド 組換えｄｎａが生産するヒト子宮プラスミノ−ゲンアクチベ−タ−
GB8528321D0 (en) * 1985-11-18 1985-12-24 Ciba Geigy Ag Modified fibrinolytic agents
ATE74379T1 (de) * 1985-12-23 1992-04-15 Chiron Corp Peptidplasminogenaktivatoren.
EP0293394B2 (en) * 1986-01-31 2003-10-29 Genetics Institute, LLC Novel thrombolytic proteins

Also Published As

Publication number Publication date
JPS62282582A (ja) 1987-12-08
DD258999A5 (de) 1988-08-10
AU602510B2 (en) 1990-10-18
HUT43108A (en) 1987-09-28
FI100802B (fi) 1998-02-27
EP0238304B1 (en) 1996-06-19
NO871086L (no) 1987-09-21
DE3751842D1 (de) 1996-07-25
GB8706249D0 (en) 1987-04-23
EP0238304A3 (en) 1988-07-06
JP2972812B2 (ja) 1999-11-08
FR2597883A1 (fr) 1987-10-30
FI871175A0 (fi) 1987-03-18
FR2597883B1 (fr) 1990-04-20
DE3751842T2 (de) 1996-11-28
FI871175A (fi) 1987-09-19
EP0238304A2 (en) 1987-09-23
NZ219654A (en) 1990-08-28
ATE139569T1 (de) 1996-07-15
NO172133B (no) 1993-03-01
GB2189249B (en) 1990-10-31
IE81073B1 (en) 2000-01-12
DK175490B1 (da) 2004-11-08
NO172133C (no) 1993-06-09
GB2189249A (en) 1987-10-21
IE870691L (en) 1987-09-18
CA1341597C (en) 2009-06-23
ES2088860T3 (es) 1996-10-01
GR3020850T3 (en) 1996-11-30
DE3708681C2 (de) 1995-08-17
HU202276B (en) 1991-02-28
PT84493B (pt) 1989-11-10
IL81937A0 (en) 1987-10-20
AU7008887A (en) 1987-09-24
IL81937A (en) 1994-07-31
DK135887D0 (da) 1987-03-17
DE3708681A1 (de) 1987-10-01
PT84493A (en) 1987-04-01
NO871086D0 (no) 1987-03-17

Similar Documents

Publication Publication Date Title
DK135887D0 (da) Human-vaevstype-plasminogenaktivator-polypeptider og fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
FI864654A0 (fi) Menetelmä modifioidun ihmisen t-PA-proteiinin valmistamiseksi
DK164594C (da) 1,4-dihydro-pyridin-3,5-yl-dicarboxylsyrederivater, farmaceutiske praeparater indeholdende disse derivater samt fremgangsmaade til fremstilling deraf
DK156053C (da) S-(carbamoyl-phenylselenyl)-derivater af glutathion og af alfa-aminomercaptocarboxylsyrer, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
DK427288A (da) Thiomethyl- og sulfinylmethylderivater med mavesyresekretorisk aktivitet, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
DE3855874D1 (de) Neue variante von menschlichem gewebeplasminogenaktivator
DK436187A (da) Polypeptider med hypocalcemivirkning og fremgangsmaade til fremstilling deraf samt laegemidler med indhold deraf
DK379287D0 (da) 1,3-propandiaminderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK362288D0 (da) Homocyclostatin- og cyclostatinholdige peptider og farmaceutiske praeparater indeholdende disse
NO902405D0 (no) Vevplasminogenaktivatorderivat, dna-sekvens og ekspresjonsplasmid, samt fremgangsmaate for fremstilling av plasmidet.

Legal Events

Date Code Title Description
PUP Patent expired